Search the weight-management forums for cagrilintide vs tirzepatide and you will find the two lined up as interchangeable rivals in the same race two once-weekly injectables, both discussed for appetite and bodyweight, often ranked against each other by percentage points lifted from unrelated studies
The FDA has not reviewed or approved compounded products for any use for safety, efficacy, or quality
As long-term research continues, regular follow-up with your healthcare provider remains essential
Point-of-care gastric ultrasound to identify a full stomach on a diabetic patient taking a glucagon-like peptide 1 receptor agonist
Under its new policy, Blue Cross Blue Shield of Massachusetts said Thursday it will continue to cover the meds, known as GLP-1s, in its standard health benefits when theyre prescribed for diabetes but not for obesity